214 related articles for article (PubMed ID: 17897854)
1. Regulation of peroxisome proliferator-activated receptor-alpha expression during lung inflammation.
Becker J; Delayre-Orthez C; Frossard N; Pons F
Pulm Pharmacol Ther; 2008; 21(2):324-30. PubMed ID: 17897854
[TBL] [Abstract][Full Text] [Related]
2. Suppression of allergen-induced airway inflammation and immune response by the peroxisome proliferator-activated receptor-alpha agonist fenofibrate.
Delayre-Orthez C; Becker J; Auwerx J; Frossard N; Pons F
Eur J Pharmacol; 2008 Feb; 581(1-2):177-84. PubMed ID: 18096152
[TBL] [Abstract][Full Text] [Related]
3. PPARalpha downregulates airway inflammation induced by lipopolysaccharide in the mouse.
Delayre-Orthez C; Becker J; Guenon I; Lagente V; Auwerx J; Frossard N; Pons F
Respir Res; 2005 Aug; 6(1):91. PubMed ID: 16091136
[TBL] [Abstract][Full Text] [Related]
4. The peroxisome proliferator-activated receptor α agonist fenofibrate decreases airway reactivity to methacholine and increases endothelial nitric oxide synthase phosphorylation in mouse lung.
Becker J; Delayre-Orthez C; Frossard N; Pons F
Fundam Clin Pharmacol; 2012 Jun; 26(3):340-6. PubMed ID: 21392098
[TBL] [Abstract][Full Text] [Related]
5. Modulation of the IL-23/IL-17 axis by fenofibrate ameliorates the ovalbumin/lipopolysaccharide-induced airway inflammation and bronchial asthma in rats.
Elaidy SM; Essawy SS; Hussain MA; El-Kherbetawy MK; Hamed ER
Naunyn Schmiedebergs Arch Pharmacol; 2018 Mar; 391(3):309-321. PubMed ID: 29288381
[TBL] [Abstract][Full Text] [Related]
6. PPARα agonist fenofibrate attenuates TNF-α-induced CD40 expression in 3T3-L1 adipocytes via the SIRT1-dependent signaling pathway.
Wang W; Lin Q; Lin R; Zhang J; Ren F; Zhang J; Ji M; Li Y
Exp Cell Res; 2013 Jun; 319(10):1523-33. PubMed ID: 23603572
[TBL] [Abstract][Full Text] [Related]
7. Enhanced expression of urocortin in lung tissues of rats with allergic asthma.
Wu Y; Zhou H; Xu Y; Li S
Biochem Biophys Res Commun; 2006 Mar; 341(2):532-40. PubMed ID: 16427607
[TBL] [Abstract][Full Text] [Related]
8. PPARα agonists inhibit inflammatory activation of macrophages through upregulation of β-defensin 1.
Ann SJ; Chung JH; Park BH; Kim SH; Jang J; Park S; Kang SM; Lee SH
Atherosclerosis; 2015 Jun; 240(2):389-97. PubMed ID: 25881202
[TBL] [Abstract][Full Text] [Related]
9. Effect of peroxisome proliferator-activated receptor alpha activators on tumor necrosis factor expression in mice during endotoxemia.
Hill MR; Clarke S; Rodgers K; Thornhill B; Peters JM; Gonzalez FJ; Gimble JM
Infect Immun; 1999 Jul; 67(7):3488-93. PubMed ID: 10377130
[TBL] [Abstract][Full Text] [Related]
10. Effect of peroxisome proliferator-activated receptor activators on tumor necrosis factor-alpha expression in neonatal rat cardiac myocytes.
Ye P; Fang H; Zhou X; He YL; Liu YX
Chin Med Sci J; 2004 Dec; 19(4):243-7. PubMed ID: 15669179
[TBL] [Abstract][Full Text] [Related]
11. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.
Hsu WH; Chen TH; Lee BH; Hsu YW; Pan TM
Food Chem Toxicol; 2014 Feb; 64():94-103. PubMed ID: 24275089
[TBL] [Abstract][Full Text] [Related]
12. Effects of ciclamilast, a new PDE 4 PDE4 inhibitor, on airway hyperresponsiveness, PDE4D expression and airway inflammation in a murine model of asthma.
Deng YM; Xie QM; Tang HF; Sun JG; Deng JF; Chen JQ; Yang SY
Eur J Pharmacol; 2006 Oct; 547(1-3):125-35. PubMed ID: 16956605
[TBL] [Abstract][Full Text] [Related]
13. Differential effects on lung cancer cell proliferation by agonists of glucocorticoid and PPARα receptors.
Liang H; Kowalczyk P; Junco JJ; Klug-De Santiago HL; Malik G; Wei SJ; Slaga TJ
Mol Carcinog; 2014 Sep; 53(9):753-63. PubMed ID: 23625588
[TBL] [Abstract][Full Text] [Related]
14. A novel PPARα agonist propane-2-sulfonic acid octadec-9-enyl-amide inhibits inflammation in THP-1 cells.
Zhao Y; Yan L; Luo XM; Peng L; Guo H; Jing Z; Yang LC; Hu R; Wang X; Huang XF; Wang YQ; Jin X
Eur J Pharmacol; 2016 Oct; 788():104-112. PubMed ID: 27318324
[TBL] [Abstract][Full Text] [Related]
15. Tumour necrosis factor alpha down-regulates the expression of peroxisome proliferator activated receptor alpha (PPARα) in human hepatocarcinoma HepG2 cells by activation of NF-κB pathway.
Lim WS; Ng DL; Kor SB; Wong HK; Tengku-Muhammad TS; Choo QC; Chew CH
Cytokine; 2013 Jan; 61(1):266-74. PubMed ID: 23141142
[TBL] [Abstract][Full Text] [Related]
16. Hepatic cytochrome P450 gene regulation during endotoxin-induced inflammation in nuclear receptor knockout mice.
Richardson TA; Morgan ET
J Pharmacol Exp Ther; 2005 Aug; 314(2):703-9. PubMed ID: 15860574
[TBL] [Abstract][Full Text] [Related]
17. Modulation of cytochrome P-450 gene expression in endotoxemic mice is tissue specific and peroxisome proliferator-activated receptor-alpha dependent.
Barclay TB; Peters JM; Sewer MB; Ferrari L; Gonzalez FJ; Morgan ET
J Pharmacol Exp Ther; 1999 Sep; 290(3):1250-7. PubMed ID: 10454501
[TBL] [Abstract][Full Text] [Related]
18. Embelia ribes ameliorates lipopolysaccharide-induced acute respiratory distress syndrome.
Shirole RL; Shirole NL; Saraf MN
J Ethnopharmacol; 2015 Jun; 168():356-63. PubMed ID: 25818695
[TBL] [Abstract][Full Text] [Related]
19. The anti-inflammatory effects of 1,1 dimethyl-4-phenylpiperazinium (DMPP) compared to dexamethasone in a guinea pig model of ovalbumin induced asthma.
Murad HA; Hasanin AH
Eur Rev Med Pharmacol Sci; 2014; 18(15):2228-36. PubMed ID: 25070830
[TBL] [Abstract][Full Text] [Related]
20. A mouse model of lung injury induced by microbial products: implication of tumor necrosis factor.
Denis M; Guojian L; Widmer M; Cantin A
Am J Respir Cell Mol Biol; 1994 Jun; 10(6):658-64. PubMed ID: 8003342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
